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A B S T R A C T
Sub-Saharan Africa concentrates the largest burden of cervical cancer worldwide. The introduction of the HPV
vaccination in this region is urgent and strategic to meet global health targets. This was a cross-sectional study
conducted in Mozambique prior to the first round of the HPV vaccine demonstration programme. It targeted girls
aged 10–19 years old identified from schools and households. Face-to-face structured interviews were con-
ducted. A total of 1147 adolescents were enrolled in three selected districts of the country. Most girls [84% (967/
1147)] had heard of cervical cancer, while 76% believed that cervical cancer could be prevented. However only
33% (373/1144) of girls recognized having ever heard of HPV. When girls were asked whether they would
accept to be vaccinated if a vaccine was available in Mozambique, 91% (1025/1130) answered positively. Girls
from the HPV demonstration districts showed higher awareness on HPV and cervical cancer, and willingness to
be vaccinated. This study anticipates high acceptability of the HPV vaccine in Mozambique and high awareness
about cervical cancer, despite low HPV knowledge. These results highlight that targeted health education
programmes are critical for acceptance of new tools, and are encouraging for the reduction of cervical cancer
related mortality and morbidity in Mozambique.
1. Introduction
Cervical cancer is the fourth most common cancer among women
worldwide, affecting half a million women each year [1]. Around 85%
of the cases occur in developing countries [2]. It is the leading cause of
cancer mortality in women in many countries, being responsible for
270,000 deaths every year [1]. Sub-Saharan Africa concentrates the
largest burden of cervical cancer worldwide, where this condition is the
leading cause of cancer mortality among women [2]. This is largely due
to the fact that in this region, the prevalence of human papillomavirus
(HPV) infection is the highest in the world, that cervical cancer
screening programmes are rare or operate with limitations, and that
high-quality treatment is either unavailable or unaffordable [3]. The
highly prevalent co-infection with human immunodeficiency virus
(HIV) in these settings also increases the risk of HPV infection and
progression to cancer [4,5].
Cervical cancer incidence rates in Mozambique are among the
highest in the world, standing at 44.8/100,000 women per year (esti-
mates for 2012). It is the most frequent cancer among women of all ages
and the leading cause of female cancer-related mortality countrywide
[6,7]. Data available in the country on HPV infection and cervical
cancer is limited. The studies that have been conducted in Mozambique
revealed the presence of HPV-DNA in up to 40% of asymptomatic
women of reproductive age [8,9], and detected HPV in all invasive
cervical cancer cases, being genotypes 16 and 18 the most commonly
found, accounting for up to 80% of cervical cancer cases [9–12]. In
addition, the national estimates on HIV prevalence are among the
highest in sub-Saharan Africa with 15% (95%CI 13.9–16) of individuals
aged 15–49 years old being HIV-infected, with higher prevalence
among women compared to men [13]. In Mozambique, a cervical
cancer screening programme, based on the visual inspection with acetic
acid (VIA) technique, was launched in 2009 in four provinces, and is
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gradually rolling out to the rest of the country [14]. Despite its re-
cognized advantages, the limited proportion of health facilities in Mo-
zambique currently implementing the program [15], the fact that the
screening program only reaches those women who seek care at health
facilities, the low acceptability of immediate treatment among con-
firmed positive cases [15], high turn-over of staff, and the technique´s
sub-optimal specificity and sensitivity [12,14], jeopardise its success as
an effective approach to reduce cervical cancer incidence country-wide.
It is clear that the introduction of the HPV vaccination to prevent
cervical cancer in low and middle-income countries is an urgent and
strategic approach to meet global health targets on women´s health
[16]. In 2011, the Global Alliance for Vaccination and Immunization
(GAVI) formalized its commitment to support the introduction of the
HPV vaccine in priority low-income countries. Under this initiative, in
2013, Mozambique was granted GAVI support for a two-year demon-
stration programme, targeting adolescent girls, in preparation for a
national scale up of vaccination against HPV. In Mozambique no data
existed to suggest the best approach to target this age group in a fea-
sible way. The evaluation of the feasibility of HPV vaccination among
adolescent girls in contexts such as that of Mozambique is critical for
the success and sustainability of HPV vaccine introduction before
moving towards national-scale implementation.
Political barriers and health systems weakness are pointed out as
major limitations for the success and the sustainability of HPV vacci-
nation programmes [3]. It is recognized that as vaccines become
available in low-income countries, the understanding of the factors
interfering with and/or contributing to the success of HPV vaccination
programmes becomes a priority [17,18]. It is critical to assess beliefs,
awareness, attitudes, and behaviours of the populations and providers
involved, conduct acceptability studies and evaluate operational as-
pects related to vaccine delivery, to better understand potential barriers
and facilitators to effective vaccine implementation [19]. Most ac-
ceptability studies of HPV vaccination have been conducted in high-
income countries and usually indicate a high interest in vaccines.
However, safety concerns, cost and socio-cultural factors have been
frequently identified as barriers, potentially interfering with uptake
[20,21]. Studies thus far conducted in sub-Saharan Africa (SSA) report
high acceptance of HPV vaccination, although cervical cancer aware-
ness and knowledge is often poor [19–21] and safety concerns mainly
based on misunderstandings regarding vaccine´s damage to adoles-
cents´ fertility [18] and perceived unsafe practices in administrating the
vaccine are consistently reported [22–35]. In Mozambique, studies
exploring the acceptability of new vaccines and preventive strategies,
suggest a good receptiveness at the community level [36–39]. However,
little is known on the awareness and knowledge about the diseases
being prevented by such vaccines, including HPV infection and cervical
cancer [15].
This study aimed to assess the awareness on cervical cancer and
HPV infection, and anticipated acceptance of HPV vaccination for
cervical cancer prevention among adolescent girls in three districts of
Mozambique in the framework of an HPV vaccine demonstration pro-
gramme. Since HPV vaccine strategies prioritize girls prior to sexual
debut, it was also an objective to understand the pattern for initiation of
sexual practices, perceived risk and self-reported protection against
cervical cancer among Mozambican adolescent girls. This information
will serve to understand the barriers and facilitators for effective HPV
vaccine implementation, and it may be of relevance to other countries
in sub-Saharan Africa and elsewhere with similar health problems and
limited resources.
2. Materials and methods
2.1. Study areas and participants
The study targeted adolescent girls aged 10–19 years old. This group
was selected based on the study´s intention to document wider issues
about prevention of HPV, as a sexually transmitted infection among
adolescents [40], but also to capture specific issues related to HPV
vaccination among the foreseen vaccination target group for Mo-
zambique.
The study was conducted between August 2013 and May 2014 in
three geographically different areas of Mozambique, namely Ka-Mavota
(peri-urban, Maputo city) and Manhiça (semi-rural, 80 km north
Maputo city) districts, both in Maputo province, in Southern
Mozambique, and in Mocímboa da Praia district (rural), in Cabo
Delgado province, in Northern Mozambique (see Fig. 1) [13,18].
2.2. Study design and data collection
This was a quantitative, cross-sectional study conducted prior to the
first round of the HPV vaccination campaign in the context of the HPV
vaccine demonstration programme in Mozambique, and concomitantly
to the education and communication activities that preceded the HPV
vaccination pilot programme. Two of the three districts where this
study was conducted (Mocímboa da Praia and Manhiça), were target
districts for the demonstration programme. Eligible participants were
identified and selected randomly from schools and households within
the selected study areas and invited to participate in the study. The
reason for this mixed method of recruitment was to ensure that girls not
enrolled in school were also captured. To capture this reality, a con-
servative assumption was made that 2/3 of the girls would be enrolled
in school. In each district, 10 schools were randomly selected and
served as the sampling frame. In each school, 30 girls were randomly
selected and invited to participate in the study. In the community, the
target sample was of at least 100 girls randomly selected per district,
which were captured from 10 randomly selected neighbourhoods per
district and identified either via the demographic surveillance platform
(in Manhiça) or a list of known 10-year old girls by the neighbourhood
secretaries.
A total sample size of 1248 adolescent girls, with a minimum sample
of 410–420 girls per site, was foreseen in order to fulfil the study ob-
jectives, based on a sample size calculation to detect 50% acceptance to
vaccinate against HPV (with 90% power and allowing for 10% re-
fusals). Each participant was provided with a study information sheet
written in the language in which the respondent was most comfortable
(either Portuguese or the main local language of the respective District).
Most interviews were conducted in Portuguese and very few of them in
the local language.
A paper-based standardised questionnaire was administered to
adolescent girls by trained female interviewers with experience con-
ducting community-based questionnaires, assessing awareness on cer-
vical cancer and HPV infection, perception of their own risks with re-
gards to HPV transmission, acceptability and willingness of adolescent
girls to be vaccinated against HPV, and perceived risks and benefits of
HPV vaccination. For the assessment of sexual behaviour patterns and
perception of risk of cervical cancer, due to the nature of the questions,
only girls aged 15–19 were inquired.
2.3. Ethics statement
Ethical approval for this study was granted by the Institutional
Review Board of the Manhiça Health Research Centre (CIBS-CISM)
[Reg. No. CIBS_CISM_09/13] and by the Ethics Review Committee of
the Hospital Clinic of Barcelona, Spain (CEIC) [Reg. No. HCB/2013/
0903]. The study was conducted in accordance with the Good Clinical
Practice Guidelines set up by the WHO, and under the provisions of the
Declaration of Helsinki, and local rules and regulations. Adolescent girls
were enrolled after they gave written consent (if 18 years of age or
older) and assent accompanied by parents´ or guardians´ written in-
formed consent (if younger than 18 years of age).
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2.4. Data management and statistical analysis
A standardised system for data entry, data management, and sta-
tistical analysis was established. All data were double entered by two
independent data clerks into form-specific databases (REDCap) [41].
Validation and cleaning were done using the same software. Data was
analysed using Stata 14.1 (Stata Corporation, College Station, TX, USA).
Data analysis consisted of descriptive statistics including frequency
distribution for demographic variables and responses obtained in rela-
tion to awareness on cervical cancer and HPV infection, sexual beha-
viour patterns and perception of health risks, preferred venues for
vaccine delivery and reasons for acceptance of HPV vaccine. Will-
ingness of adolescent girls to be vaccinated was recorded in terms of the
proportion of adolescent girls that hypothetically would accept to be
vaccinated. Data are presented as mean (SD) for continuous variables.
Differences between proportions were compared using the Pearson´s
chi-squared test or Fisher's exact test if the application conditions of the
former were not met. For quantitative variables, the ANOVA test was
used for group comparisons. Associations between outcome variables
(knowledge of HPV and cervical cancer, vaccine acceptability and
sexual behaviour) and socio-demographic variables (study site, age
group, level of education, marital status, literacy, and occupation) were
explored using logistic regression. Multivariable models were built
using a stepwise procedure, where the variables study site and age
category were forced to remain in the model. The significance level was
set at p < 0.05. Missing values were coded as such and excluded from
analysis. Adolescents were defined, according to WHO definition, as
young people between the ages of 10 and 19 years [40]. Level of
education was categorised as having completed primary school studies
or studies higher than primary school. Two age groups were defined,
whether being between 10 and 14 years old, or between 15 and 19
years old.
3. Results
3.1. Demographic characteristics of study adolescent girls
A total of 1147 Mozambican adolescent girls from three selected
districts (357 in Manhiça, 402 in Ka-Mavota, and 388 in Mocímboa da
Praia), accepted to participate in the study, of which 85% (970/1141)
were recruited at school and 15% (171/1141) at their households.
Mean age of participants was 14.4 years [standard deviation (SD) 2.8],
being 627 girls between 10 and 14 years of age, and 520 girls between
15 and 19 years of age. Baseline characteristics of study participants are
shown in Table 1.
3.2. Awareness of HPV infection and cervical cancer
The majority, [84% (967/1147)] of girls had heard of cervical
cancer, and 64% of them (725/1139) reported the uterus as the main
organ affected by cervical cancer; however, only 33% of the partici-
pants (373/1144) recognized having ever heard of HPV infection; with
higher knowledge on HPV in the districts where the HPV demonstration
programme was being conducted (58% in Mocímboa da Praia, and 28%
in Manhiça) Seventy-one percent of adolescent girls (685/963) con-
sidered sexual transmission as the principal mode of acquisition of
cervical cancer followed by history of cancer in the family (21%) (See
Table 2). Regarding sources of information about HPV and cervical
cancer, the National HPV vaccine demonstration programme, which
was under preparation at the time of the conduction of the present
study.
3.3. Knowledge on prevention of cervical cancer and HPV vaccine
Seventy six per cent (866/1146) of study participants were aware
that cervical cancer can be prevented (see Table 3). When asked about
which tools or strategies could prevent cervical cancer, 64% (551/855)
reported vaccination, though only 36% (407/1133) had ever heard of a
specific vaccine to prevent it (see Tables 3, 4). About best timing when
the vaccine should be given, 62% (532/865) of participants reported
that before sexual debut, however 15% (133/865) reported that at any
age.
3.4. Acceptability of HPV vaccine by Mozambican adolescent girls
When girls were asked whether they would accept to be vaccinated
if a vaccine was available in Mozambique, 91% (1025/1130) of girls
answered positively. This high HPV vaccine acceptability was observed
across all study sites (see Table 4). Across sites, the preferred place to be
vaccinated was the health centre (61%), followed by the school (34%)
and the community (16%).
3.5. Factors associated with awareness about HPV and cervical cancer and
acceptability of HPV vaccine among Mozambican adolescent girls
Adolescent girls from Mocímboa da Praia, in Northern Mozambique,
showed higher knowledge about what HPV infection and cervical
cancer represent and its prevention, followed by girls from Manhiça
district, in Southern Mozambique (see Table 5). A better understanding
of HPV infection and its relation to cervical cancer was seen among
older adolescents (15–19 years of age), compared to young ones (10–14
years). The level of education (higher than primary) was associated
with a greater knowledge about cervical cancer and how it could be
prevented.
No differences were seen on the acceptability of the HPV vaccine
across study sites (p= 0.118) or age groups (p= 0.323) (see
Supplementary Table S1). Factors associated with increased accept-
ability of HPV vaccine were level of education (adjusted OR, 4.85, [95%
CI 2.24–10.53]; p < 0.001 for girls with education higher than pri-
mary school compare to those with only primary school studies), having
some knowledge about cervical cancer (adjusted OR, 2.29, [95% CI
1.36–3.83]; p= 0.002), and having some knowledge about prevention
of cervical cancer (adjusted OR, 2.62, [95% CI 1.40–4.90]; p= 0.007).
3.6. Pattern of sexual behaviour and perception of risk of cervical cancer
among older adolescent girls (15–19 years of age)
Overall, 94% (481/514) of older adolescent girls interviewed had
heard of sexually transmitted infections (STIs). Of them, 84% (405/
480) reported that STIs could be prevented by using condoms, and 23%
(109/480) by having only one sexual partner (see Table 6). Sixty one
percent of them (314/514) said to be sexually active by the time of the
interview, being the mean reported age at first sexual intercourse of
15.7 years [standard deviation (SD) = 1.6]. Twenty three per cent (70/
310) of the participants reported early debut of sexual relations (before
15 years of age), being Mocímboa da Praia the district where higher
proportion of early beginners (55%) was observed (see Table 6).
Of those girls who had initiated sexual relations, 43% (132/307)
reported one previous sexual partner, 39% (121/307) two sexual
partners, and 18% (54/307) three or more sexual partners. Regarding
use of condoms, 76% (237/313) reported to use them (52% always and
48% sometimes). Nearly 60% (257/451) of participants felt they were
at risk of cervical cancer, being Mocímboa da Praia (70%) and Manhiça
(57%) the districts where perception of such risk was higher.
4. Discussion
To our knowledge, this is the first study conducted in Mozambique
assessing the awareness of cervical cancer and willingness to be vac-
cinated against HPV among adolescent girls. This study was carried out
in advance of the roll out of HPV vaccination countrywide. Overall,
knowledge about cervical cancer and its prevention was high among
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girls, with 84% of them having heard of cervical cancer, while 76%
believed that cervical cancer could be prevented, and recognising
vaccination as the main strategy to prevent it. However, the level of
awareness about HPV infection was low, with only a third of girls that
recognized having heard about this infection. In addition, acceptability
levels of the HPV vaccine was high across sites, with an overall 91% of
the girls willing to be vaccinated should the vaccine be available in the
country.
Most studies in SSA on awareness about cervical cancer and HPV
vaccine consistently reported that while levels of knowledge are gen-
erally low, willingness to vaccinate against HPV is high
[17–27,29–33,35,42,43]. In this study, both awareness of cervical
cancer (despite low awareness of HPV infection), and willingness to
vaccinate against HPV was very high across the three study districts.
Our findings on acceptability are in accordance with results from other
settings in SSA and worldwide. In our population, main determinants of
acceptability and willingness to be vaccinated against HPV were the
level of education, together with previous knowledge about cervical
cancer and available tools to prevent it.
Several studies in SSA have shown high levels of awareness in the
population and acceptability of the HPV vaccine following HPV vacci-
nation campaigns [18,20,25]. This study showed both high awareness
and anticipated acceptability, particularly in the two study districts
(Mocímboa da Praia and Manhiça) target for the first vaccination
campaign of the HPV vaccine demonstration programme in Mo-
zambique. This reflects the effect of already on-going circulating in-
formation (provided as part of education and communication activ-
ities), prior to vaccination campaign in pilot areas. Indeed, in these two
districts the main source of information for HPV and cervical cancer
reported by study participants were the information activities pre-
ceding the HPV vaccination campaign. These findings align with the
content of the information spread through the demonstration awareness
campaign, which consisted in community radio spots broadcasted in
advance of the campaign, question and answers booklets distributed in
the communities, and posters posted at health facilities and schools.
While posters and radio spots focused on the vaccine and its relevance
Table 1
Demographic characteristics of adolescent girls.
Study site
Total Mocímboa da Praia Manhiça Ka-Mavota
N N (%) N (%) N (%) p-valuea
Participants 1147 388 (34) 357 (31) 402 (35)
Age (years)* 14.4 (2.8) 13.4 (2.4) 14.0 (2.5) 15.7 (2.9) < 0.001
n (%) n (%) n (%) n (%)
Age group (years) 10–14 627 (55) 265 (68) 215 (60) 147 (37) <0.001
15–19 520 (45) 123 (32) 142 (40) 255 (63)
n/N (%) n/N (%) n/N (%) n/N (%)
Site of interview At school 970/1141 (85) 327/388 (84) 309/356 (87) 334/397 (84) 0.523
At the community 171/1141 (15) 61/388 (16) 47/356 (13) 63/397 (16)
Level of education Primary school 690/1094 (63) 302/356 (85) 249/357 (70) 139/381 (36) <0.001
Higher than primary 404/1094 (37) 54/356 (15) 108/357 (30) 242/381 (64)
Literacy Reads and/or writes 986/1125 (88) 256/373 (69) 336/354 (95) 394/398 (99) <0.001
Marital status Single 1071/1142 (94) 355/387 (92) 322/356 (90) 394/399 (99) <0.001
Joined or married 71/1142 (6) 32/387 (8) 34/356 (10) 5/399 (1)
Occupation Non-worker 944/1128 (84) 308/385 (80) 286/350 (82) 350/393 (89) 0.001
Worker 184/1128 (16) 77/385 (20) 64/350 (18) 43/393 (11)
a Chi-squared test.
* Arithmetic Mean (SD), p-value with ANOVA test.
Table 2
Knowledge and awareness of HPV infection and cervical cancer (CC) among adolescent girls.
Study site
Total Mocímboa da Praia Manhiça Ka-Mavota
n/N (%) n/N (%) n/N (%) n/N (%) p-value*
Ever heard of cervical cancer? 967/1147 (84) 296/388 (76) 336/357 (94) 335/402 (83) <0.001
Organs affected by CC Uterus 725/1139 (64) 226/385 (59) 283/356 (79) 216/398 (54) <0.001
Breast 183/1139 (16) 10/385 (3) 46/356 (13) 127/398 (32)
Others 51/1139 (4) 44/385 (11) 7/356 (2) 0/398 (0)
Don´t know 180/1139 (16) 105/385 (27) 20/356 (6) 55/398 (14)
Recognized signs of CC Abnormal vaginal bleeding 344/960 (36) 167/292 (57) 114/336 (34) 63/332 (19) <0.001
Vaginal discharge 331/960 (34) 143/292 (49) 134/336 (40) 54/332 (16) <0.001
Dyspareunia 281/960 (29) 39/292 (13) 103/336 (31) 139/332 (42) <0.001
Mode of acquisition of CC Sexual transmission 685/963 (71) 243/294 (83) 249/336 (74) 193/333 (58) <0.001
History of cancer in the family 199/963 (21) 36/294 (12) 60/336 (18) 103/333 (31)
Others 9/963 (1) 2/294 (1) 5/336 (1) 2/333 (1)
Don´t know 70/963 (7) 13/294 (4) 22/336 (7) 35/333 (11)
Ever heard of HPV infection? Yes 373/1144 (33) 224/387 (58) 98/356 (28) 51/401 (13) <0.001
Source of information Through HPV Demo Program 256/608 (42) 157/237 (66) 58/100 (58) 41/271 (15) <0.001
for HPV and CC Mass media 203/608 (33) 37/237 (16) 7/100 (7) 159/271 (59) <0.001
At the health centre 76/608 (13) 20/237 (8) 11/100 (11) 45/271 (17) 0.019
At the community 44/608 (7) 11/237 (5) 6/100 (6) 27/271 (10) 0.061
* Chi-squared test.
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to a healthy present and future life, the questions and answers booklet
focused on the female reproductive tract, characteristics of cervical
cancer, modes of transmission and prevention.
Interestingly, the preferred place for vaccination was the health
centre (61%) across sites and age groups, despite the limited routine
contacts of adolescents with the health system and the generally low
attendance to adolescent-specific services in settings like this [44]. This
finding is not aligned, in principle, with the demonstration program
strategy being considered by the Ministry of Health of Mozambique
(MoH) at the time. It would be risky for the MoH to attempt a solely
facility-based approach grounded on girls preference, given the existing
evidence of low adherence to health facilities among healthy adolescent
girls, and high coverage of school-based vaccination demonstrated in
Rwanda, South Africa [45], Tanzania and Uganda [46]. In order to
address girls preferences, the appropriate option to the Mozambique
MoH would be to focus on school-based delivery as the main approach
[17] in addition to a community- and health facility-based strategy to
reach those girls who never enrolled in school or dropped out by the age
they were to be vaccinated (10 years).
It is noteworthy to mention that while we found a perceived
Table 3
Knowledge and awareness about prevention of cervical cancer (CC) and HPV vaccine among adolescent girls.
Study site
Total Mocímboa da Praia Manhiça Ka-Mavota
n/N (%) n/N (%) n/N (%) n/N (%) p-value*
Thinks cervical cancer Yes 866/1146 (76) 269/388 (69) 322/357 (90) 275/401 (69) <0.001
can be prevented No 93/1146 (8) 22/388 (6) 23/357 (6) 48/401 (12)
Don´t know 187/1146 (16) 97/388 (25) 12/357 (3) 78/401 (19)
If yes, modes of prevention Vaccination 551/855 (64) 144/268 (54) 224/319 (70) 183/268 (68) <0.001
By using condoms 151/855 (18) 47/268 (18) 65/319 (20) 39/268 (15) 0.183
Delaying sexual initiation 145/855 (17) 80/268 (30) 37/319 (12) 28/268 (10) <0.001
Less sexual partners 104/855 (12) 46/268 (17) 34/319 (11) 24/268 (9) 0.009
When you think vaccination Before sexual initiation 532/865 (62) 176/260 (68) 213/329 (65) 143/276 (52) <0.001
should be given At any age 133/865 (15) 40/260 (15) 24/329 (7) 69/276 (25)
After 18 years of age 102/865 (12) 18/260 (7) 35/329 (11) 49/276 (18)
After sexual inititiation 72/865 (8) 14/260 (5) 52/329 (16) 6/276 (2)
Don´t know 17/865 (2) 5/260 (2) 4/329 (1) 8/276 (3)
Others 9/865 (1) 7/260 (3) 1/329 (0) 1/276 (0)
* Chi-squared test.
Table 4
Acceptability and willingness to vaccinate against HPV among adolescent girls.
Study site
Total Mocímboa da Praia Manhiça Ka-Mavota
N (%) n (%) n (%) n (%) p-value*
If available in Mozambique, would accept 1025/1130 (91) 349/387 (90) 318/353 (90) 358/390 (92) 0.658
to be vaccinated?
Preferred place to be At the health centre 620/1012 (61) 162/345 (47) 193/314 (61) 265/353 (75) <0.001
Vaccinated At school 347/1012 (34) 75/345 (51) 111/314 (35) 1/353 (17) <0.001
At the community 164/1012 (16) 77/345 (22) 53/314 (17) 34/353 (10) <0.001
* Chi-squared test.
Table 5
Factors associated with knowledge about HPV, cervical cancer and its prevention: adjusted multivariate model.
HPV knowledge* Cervical cancer knowledge* Knowledge about prevention of cervical cancer*
n/N ORa (95% CI) p-value n/N OR (95% CI) p-value n/N OR (95% CI) p-value




1 <0.001 272/356 1 <0.001 246/265 1 <0.001
Manhiça 98/355 0.25 (0.18–0.34) 336/357 4.49 (2.70–7.47) 322/345 0.99 (0.53–1.87)
Kha-Mavota 51/398 0.09 (0.06–0.13) 319/381 0.98 (0.65–1.48) 262/309 0.28 (0.15–0.51)
Age group 10–14 195/
622
1 <0.001 480/602 1 0.003 434/488 1 0.586
(years) 15–19 177/
517
1.79 (1.31–2.44) 447/492 1.94 (1.25–3.03) 396/431 1.17 (0.66–2.06)
Marital status Single 326/
1068
1 0.002
Joined/married 46/71 2.50 (1.41–4.44)
Education Primary school 557/690 1 0.007 496/558 1 0.008
> than
primary
370/404 2.02 (1.21–3.37) 334/361 2.37 (1.26–4.48)
a OR: Odds Ratio.
* Number of observations: 1139 in HPV knowledge model, 1094 in cervical cancer knowledge model and 919 in prevention model.
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understanding by adolescent girls that sexually transmitted infections
(STIs) were associated with increased risk of suffering from cervical
cancer, there was a huge disparity between awareness of STIs in general
and awareness of HPV infection (only 33% of adolescent girls had ever
heard about HPV, versus 91% who were aware of other STIs, such as
HIV or syphilis). In addition, while willingness to be vaccinated to
prevent cervical cancer was high, participants showed little under-
standing about best timing to be vaccinated and the link between the
efficacy of the vaccine and sexual debut [47]. The low awareness of
HPV infection reported together with the high willingness to be vac-
cinated seemed paradoxical, but this might be explained by the ado-
lescents´ understanding and perception that the purpose of vaccination
was to prevent cervical cancer rather than to avoid a sexually trans-
mitted infection.
Mean age at first sexual intercourse was of 15 years across districts
and nearly 25% of girls had initiated sexual relations before the age of
15. This finding are aligned with the rates of child marriage in
Mozambique, being the highest in Northern provinces; 17.6% of girls in
Cabo Delgado between the ages of 20 and 24 years were married before
15 years of age [48]. These findings, including early initiation of sexual
relations (before 15 years of age) and reported number of sexual part-
ners, are similar to those from other settings in SSA [14,49]. This is,
coupled with the inconsistent pattern of condom use reported by the
study participants, of particular concern, given the high prevalence of
HIV infection in the country, also highly prevalent in the youngest
populations, and the synergistic effects of the HIV and HPV co-infection
[13,50].
Despite the wide anticipated overall acceptance of the HPV vaccine
observed across sites this study, we found differences on knowledge and
perceived risk for cervical cancer. Adolescent girls from the district in
the periphery of the capital, Ka-Mavota, showed the poorest knowledge
about cervical cancer and the HPV vaccine. This may be explained
because this area was not a target HPV vaccination demonstration site,
reflecting the imbalance of information spread between targeted and
non-targeted areas. When comparing the two targeted sites for HPV
vaccine demonstration, baseline knowledge either on HPV and vaccines
for prevention of cervical cancer was the highest in Mocímboa da Praia,
a remote rural area in Northern Mozambique, compared to Manhiça,
also a rural area, but relatively proximate to the capital city in the
South. Moreover, in Mocímboa district a much higher proportion of
adolescent girls reported feeling at risk of cervical cancer compared to
the other sites in the south of the country. The results on higher
awareness about HPV and cervical cancer among Mocímboa da Praia
adolescents seem to contrast their reported riskier sexual behaviour,
where the average age at sexual debut was lower compared to other
districts [51], and the proportion of girls reporting early initiation of
sexual relations (before 15 years) and those reporting having had 3 or
more sexual partners the highest. Such contrast between knowledge,
perception of risk and actual risk behaviours had been reported pre-
viously in Mozambique [49]. An explanation for this finding might be
that their experience about early initiation of sexual and reproductive
life [52,53] leads to a higher receptiveness to the idea of a vaccine to
prevent cervical cancer.
5. Conclusions
In conclusion, our study anticipated high acceptability of HPV
vaccine in Mozambique indicated by willingness to be vaccinated
among adolescents across different settings of the country, as well as
the adequate awareness about cervical cancer, prior to the roll out of
vaccination against HPV. Specific aspects of knowledge of aetiology of
cervical cancer need improvement. Our results highlight that relevant
targeted health education programmes across the country, as those
provided as part of the HPV vaccine demonstration programme, are
critical for the acceptance of new tools to prevent cervical cancer, and
that delivery strategies should address socio-cultural specificities across
the country. The results coming from this study are encouraging and
favourable to advance towards reduction in cervical cancer related
mortality and morbidity in Mozambique.
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